Analysis of Incompletely Excised BCCs (4.68%)

Slides:



Advertisements
Similar presentations
Basal Cell Nevus Syndrome Daniel Berg M.D., FRCPC Director, Dermatologic Surgery University of Washington.
Advertisements

NonMelanoma Skin Cancer Dr David Burdon-Jones Consultant Dermatologist Dorset County Hospital Foundation Trust Interactive.
Non-Melanoma Skin Cancer Treated with Electronic Brachytherapy: Results at Two Years Ajay Bhatnagar MD, MBA Cancer Treatment Services Arizona Casa Grande,
Nonmelanoma Skin Tumor
Eyelid Cancer and Reconstruction
Infiltrating Basal Cell Carcinoma Maysoon ALGain Dermatology Demonstrator KAAU.
MALIGNANT EYELID TUMOURS
Basal Cell Carcinoma Presented by: Bill V. Way, D.O. AOCD Board Certified Dermatologist Residency in US Army at Walter Reed Consultant for Charlton Methodist.
Skin Cancer Carlos Garcia MD Dermatology at OUHSC No conflicts of interest to disclose.
Indications for Mohs Surgery
Clinico-Pathological Conference (CPC) Meet Karpagam Medical College Hospital
Squamous Cell Carcinoma: An update on Treatment and Management
Presented by Robert S. Stern, M.D. at the September 10, 2003 meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee.
Skin Cancer Incidence Over 1 million new cases of BCC & SCC
SKIN CANCER KARINA PARR, MD RONALD GRIMWOOD, MD KARA KENNEY.
MOHS MICROGRAPHIC SURGERY: A HISTORICAL PERSPECTIVE Patricia Ting, BSc, Anatoli Freiman, MD Division of Dermatology, McGill University Health Centre, Montreal,
كوتر براي لوزه nostril Mohs micrographic surgery is an approach to skin cancer removal that aims to achieve the highest possible rates of cure.
Acinic Cell Carcinoma of the Parotid Gland Metastatic to the Epidermis of the Back Pilcher R. Davidson MJC. Department of Oral and Maxillofacial Surgery,
Transcranial orbital exenteration: An extended approach for intraorbital malignancies Lip Teh Matthew Hansen Royal Perth Hospital.
C&H Skin Cancer Referral Pathway 2013 Dr Sara Ritchie CCG GP Dermatology Lead.
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
Coding and Reimbursement for Mohs Micrographic Surgery
BCCs & GPs Dr Victoria Brown Consultant Dermatologist West Hertfordshire Hospitals NHS Trust.
From General Surgery to Dermatology : A Historical Perspective of Mohs Micrographic Surgery By: Patricia Ting, BSc, University of Calgary & Anatoli Freiman,
External Ear Basosquamous cell carcinoma 1 Instructor: 杜宗陽主任 Reporter: 張廷碩.
Common MMalignant Skin Tumours, M elanoma, Biopsy M ethods, Surgical
National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.
The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.
It is essential to obtain the exact history of the hypersalivation as well as a thorough and complete past medical history. Oral evaluation should be performed,
Supraclavicular metastasis from urothelial bladder carcinoma: A case report S. Farmahan, T. Mirza, P. Ameerally Oral Maxillofacial Department, Northampton.
Photodynamic Therapy for Pre-cancerous lesions of the skin Alan Milligan Clinical Nurse Specialist for Non-Melanoma Skin Cancers.
Ka-Wai, Liu; Tsung-Chun, Huang; Hung-Chi, Chen
ORAL RECONSTRUCTION AFTER EXCISION OF SOFT TISSUE MALIGNANCIES.
Indications for gastrectomy after incomplete EMR for early gastric cancer Hideki Nagano1,4, Shigekazu Ohyama1, Tetsu Fukunaga1, Yasuyuki Seto1, Junko Fujisaki2,
“Malignant skin tumors”
Mohs micrographic surgery SWAG network service Update May 2016
Non-melanoma skin cancer reconstruction of the head and neck region at Northampton General Hospital: a case series. Iqbal U1, Kapasi F2 Ameerally P3 1.
Indications for Breast MR Imaging
Skin Cancer 高雄長庚醫院放射腫瘤科 許軒之.
Operative Approach and
Advanced Marjolin`s ulcer of the scalp
Lako S, Daka A, Nurka T, Dedej T, Memishaj S
Skin Cancer Diagnoses and Treatments.
Clinicopathological features and outcome of Head & Neck Cancer in Pakistan 1A Jamshed, 1R Hussain, 2S Jamshed, 1A A Syed, 1A Loya, 1M A Shah, 1U Majeed.
Department of General Surgery, Upper Gastrointestinal Unit,
Daniel Keith – Dermatology Registrar
Basal cell carcinoma: Review Deba P Sarma, MD., Omaha
The treatment of neck and parotid gland in cutaneous squamous cell carcinoma of face and forehead and the review of literature  Mehmet Haksever, Davut.
SQUAMOUS CELL CARCINOMA OF THE SKIN IN A TROPICAL SETTING
P. Surda, S. Hampal, H. Fowler, R. Goggins
Prognosis of younger patients in non-small cell lung cancer
Emily Decker1, Ania Mejsak1, Alan Askari2, Shirley Chan1
Audit of Results of Lid Tumour Excision
Emerging Trends in the Treatment of Advanced Basal Cell Carcinoma
Prof.S.M.Haider Faisal Hameed Wahab Kadri
SKIN CANCER.
Demarcation of Nonmelanoma Skin Cancer Margins in Thick Excisions Using Multispectral Polarized Light Imaging  Anna N. Yaroslavsky, Victor Neel, R. Rox.
‘Improving Outcomes for people with skin tumours, including Melanoma’
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Safety of community-based minor surgery performed by GPs: an audit in different settings by Jonathan Botting, Ana Correa, James Duffy, Simon Jones, and.
Dr Yve Zhang (Consultant, Cellular Pathology)
M. Pascone, G. Papa  British Journal of Plastic Surgery 
Tumor Recurrence 5 Years after Treatment of Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma  Mary-Margaret Chren, Eleni Linos, Jeanette S.
Reconstruction of nasal defects using modified composite grafts
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma  Howard Sofen, MD,
R.W. Griffiths, S.K. Suvarna, J. Stone 
Prognosis of angiosarcoma at different anatomic sites
The utility of optical coherence tomography for diagnosis of basal cell carcinoma: a quantitative review N. Reddy and B.T. Nguyen Department of Dermatology,
SCC MDT Service Evaluation
Presentation transcript:

Analysis of Incompletely Excised BCCs (4.68%) The fate of incompletely excised Basal Cell Carcinomas of the head and neck, do we need to re-excise? A series of 1410 patients Tarun Mittal BDS MFDSRCS (Ed) Senior House Officer William Smith FDSRCS FRCS (Ed) FRCS (Eng) Consultant Oral & Maxillofacial Surgeon Phillip Ameerally BDS MBBS (Hons) FDS FRCS Consultant Oral & Maxillofacial Surgeon Department of Oral and Maxillofacial Surgery Introduction BCCs are the most common skin malignancy1 BCCs are known to nearly never metastasise2 Aggressiveness of the lesion can be related to its subtype3 Principal treatment is surgical removal with a margin4 British Association of Dermatologists quote 85% cure rate with 3mm margin, 95% with 5mm5,6 Incomplete excision rates range 0.7-9%7,8 Analysis of Incompletely Excised BCCs (4.68%) Aims Determine incomplete excision rate Evaluate incidence of residual tumour following re-excision Identify any prognostic factors of incomplete excision Methods Prospectively maintained databases of 2 surgeons 1471 BCCs in 1070 patients Lesions excised with 3-5mm margin, unless poorly defined or morpheic Reconstruction with Primary closure Local flap Wolfe Graft Delayed closure Healing by secondary intention Results 1070 patients, 1471 BCCs 57% Female, average age 64.7 75% referred from dermatologists 83% treated under LA 15.3% with preoperative histology available Incomplete excision rate 4.68% Cohort Characteristics Distribution of lesions Site % of total Nose 23.98 Cheek 19.02 Temple 15.37 Forehead 13.23 Ear 7.51 Site % of total Scalp 5.38 Lip 5.10 Neck 4.69 Eyelid 4.14 Chin 1.59 High Risk Sites Discussion Nose Cheek and Ear represent anatomical sites most commonly associated with incomplete excision Nose (6.72% incomplete excision rate) Alar (9.72%) most problematic region Cheek (3.80% incomplete excision rate) Nasolabial fold (13.04%) most problematic region Ear (12.15% incomplete excision rate) Concha (25%) and Posterior Auricular Sulcus (14.70%) most problematic regions Majority of lesions located in ‘high risk’ sites of head and neck Areas associated with increased incidence of incomplete excision represent areas with reduced excess tissue available More conservative margins taken Reconstruction more difficult Patients with BCCs are often of advanced age with other significant co-morbidities 52.24% of incompletely excised lesions underwent further excision 60% of these lesions displayed histological signs of residual tumour Histology of lesions Histology % of total Nodular 34.29 Mixed 21.76 Ulcerative 10.52 Unknown 10.45 Morphaeic 9.02 Infiltrative 6.01 Histology % of total Multicentric 2.65 Micronodular 1.57 Cystic 1.15 Pigmented 1.00 Superficial 0.72 Basosquamous 0.21 Adenoid 0.14 Conclusions Incomplete excision rate of 4.68% Residual tumour present in 60% of lesions that were treated with further surgery Watch and wait is a valid for selective cases Lesions of the Nose, Ear and Nasolabial fold are at higher risk of incomplete excision These lesions may be candidates for earlier excision or Mohs surgery References J. S. Gilbody et al, 1994. What causes basal cell carcinoma to be the commonest cancer? Australian Journal of Public Health, 18(2), pp.218-21. P. T. Ting, et al, 2005. Metastatic basal cell carcinoma: report of two cases and literature review. Journal of Cutaneous Medicine and Surgery, 9(1), pp.10-15. D. Costantino et al, 2006. Basosquamous carcinoma—an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. Journal of Plastic, Reconstructive and Aesthetic Surgery, 59(4), pp.424-28. N. R. Telfer et al, 1999. Guidelines for the management of basal cell carcinoma. British Journal of Dermatology, 141(1), pp.415-23. H. Breuninger et al, 1991. Prediction of subclinical tumor infiltration in basal cell carcinoma. Journal of Dermatologic Surgery and Oncology, 17(7), pp.574-78. N. R. Telfer et al, 2008. Guidelines for the management of basal cell carcinoma. British Journal of Dermatology, 159(1), pp.35-48. A. W. Wilson et al, 2004. Surgical management of incompletely excised basal cell carcinomas of the head and neck. British Journal of Oral and Maxillofacial Surgery, 42(4), pp.311-14. Griffiths, R.W., 1999. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision. British Journal of Plastic Surgery, 52(1), pp.24-28.